Filtered By:
Infectious Disease: SARS
Procedure: Anesthesia

This page shows you your search results in order of date.

Order by Relevance | Date

Total 12 results found since Jan 2013.

Bibliometric analysis of the worldwide scientific production on COVID-19 infection and cerebrovascular disease
CONCLUSION: It was observed that the United States was the country with the highest scientific production on COVID-19 and cerebrovascular disease in the year 2020 in the different health areas; however, more research is still needed worldwide for a better analysis of the bibliometric indicators on the subject.PMID:37706386 | PMC:PMC10284493 | DOI:10.4103/aca.aca_70_22
Source: Annals of Cardiac Anaesthesia - September 14, 2023 Category: Anesthesiology Authors: Camila Palomino-Leyva Jhonny Rivera-Recuenco Alicia Fernandez-Giusti John Barja-Ore Yesenia Retamozo-Siancas Frank Mayta-Tovalino Source Type: research

NobleStitch PFO Closure for Recurrent Strokes in a Patient on ECMO with COVID-19
Severe hypoxemia secondary to SARS-COV-2 (COVID-19) pneumonia is a significant contributor to morbidity and mortality.1 Patent foramen ovales (PFOs) can exacerbate hypoxemia through an intracardiac shunt, slowing recovery and worsening outcomes.2-4 Cryptogenic stroke is a complication commonly associated with PFOs; however, current guidelines do not address PFO management in COVID-19 patients who experience recurrent paradoxical emboli, especially in the setting of COVID-19 pneumonia, increased right-sided pressures, and a hypercoagulable state.
Source: Journal of Cardiothoracic and Vascular Anesthesia - October 18, 2022 Category: Anesthesiology Authors: Perry A. Stout, Nika Samadzadeh Tabrizi, Matt Tribble, Tanya Richvalsky, Cindy Youn, Brion Winston, Alexander D. Shapeton, Sridhar R. Musuku Tags: Case Report Source Type: research

NobleStitch Patent Foramen Ovales Closure for Recurrent Strokes in a Patient with COVID-19 on Extracorporeal Membrane Oxygenation
SEVERE HYPOXEMIA, secondary to the SARS-COV-2 (COVID-19) pneumonia, is a significant contributor to morbidity and mortality.1 Patent foramen ovales (PFOs) can exacerbate hypoxemia through an intracardiac shunt, slowing recovery and worsening outcomes.2-4 Cryptogenic stroke is a complication commonly associated with PFOs; however, current guidelines do not address PFO management in COVID-19 patients who experience recurrent paradoxical emboli, especially in the setting of COVID-19 pneumonia, increased right-sided pressures, and a hypercoagulable state.
Source: Journal of Cardiothoracic and Vascular Anesthesia - October 18, 2022 Category: Anesthesiology Authors: Perry A. Stout, Nika Samadzadeh Tabrizi, Matt Tribble, Tanya Richvalsky, Cindy Youn, Brion Winston MD, Alexander D. Shapeton, Sridhar R. Musuku Tags: Case Report Source Type: research

IJERPH, Vol. 18, Pages 9464: The Impact of the Pandemic on Acute Ischaemic Stroke Endovascular Treatment from a Multidisciplinary Perspective: A Nonsystematic Review
Conclusions: Adequate management of AIS patients requiring mechanical thrombectomy during the pandemic is of paramount importance to maximise the benefit of the endovascular procedure. MDT work and familiarity with NORA principles decrease the negative impact of the disease on the clinical outcomes for AIS patients.
Source: International Journal of Environmental Research and Public Health - September 8, 2021 Category: Environmental Health Authors: Grigonyte Kraujelyte Januskeviciute Semys Kriukelyte Kontrimaviciute Valeviciene Jatuzis Tags: Review Source Type: research

Anesthetic Management for Endovascular Treatment of Stroke in Patients With Coronavirus Disease 2019: A Case Series
A significant number of patients with coronavirus disease 2019 develop strokes with large vessel obstructions that may require endovascular treatment for revascularization. Our series focuses on periprocedural issues and the anesthetic management of these patients. We analyzed medical records of 5 patients with positive reverse transcription polymerase chain reaction tests for severe acute respiratory syndrome coronavirus 2 during their hospitalization who underwent endovascular treatment at our hospital between March and mid-June 2020. We found that our patients were different from the typical patients with ischemic strok...
Source: A&A Case Reports - May 1, 2021 Category: Anesthesiology Tags: Case Series Source Type: research

Atrial appendage angiotensin-converting enzyme-2, aging and cardiac surgical patients: a platform for understanding aging-related coronavirus disease-2019 vulnerabilities
Purpose of review Hospitalizations for COVID-19 dramatically increase with age. This is likely because of increases in fragility across biological repair systems and a weakened immune system, including loss of the cardiorenal protective arm of the renin--angiotensin system (RAS), composed of angiotensin-converting enzyme-2 (ACE2)/angiotensin-(1--7) [Ang-(1--7)] and its actions through the Mas receptor. The purpose of this review is to explore how cardiac ACE2 changes with age, cardiac diseases, comorbid conditions and pharmaceutical regimens in order to shed light on a potential hormonal unbalance facilitating SARs-CoV...
Source: Current Opinion in Anaesthesiology - March 12, 2021 Category: Anesthesiology Tags: SPECIAL COMMENTARIES Source Type: research